Literature DB >> 10858370

Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents.

J D Wong1, J R Barash, R F Sandfort, J M Janda.   

Abstract

Ninety-two strains of Yersinia pestis recovered over a 21-year period were evaluated for susceptibility to traditional and newer antimicrobial agents. In vitro resistance was noted only against rifampin and imipenem (approximately 20% of strains). The most active compounds (MIC at which 90% of the isolates tested are inhibited) against Y. pestis were cefixime, ceftriaxone, trimethoprim-sulfamethoxazole, and trovafloxacin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858370      PMCID: PMC90001          DOI: 10.1128/AAC.44.7.1995-1996.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Pneumonic plague--Arizona, 1992.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1992-10-09       Impact factor: 17.586

2.  Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Authors:  M Galimand; A Guiyoule; G Gerbaud; B Rasoamanana; S Chanteau; E Carniel; P Courvalin
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

3.  In vitro antimicrobial susceptibilities of strains of Yersinia pestis.

Authors:  M D Smith; D X Vinh; T T Nguyen; J Wain; D Thung; N J White
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

4.  From the Centers for Disease Control and Prevention. Human plague--India, 1994.

Authors: 
Journal:  JAMA       Date:  1994-10-19       Impact factor: 56.272

Review 5.  Yersinia pestis--etiologic agent of plague.

Authors:  R D Perry; J D Fetherston
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.

Authors:  J A Frean; L Arntzen; T Capper; A Bryskier; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

  6 in total
  8 in total

1.  Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis.

Authors:  David R Lonsway; Sandra K Urich; Henry S Heine; Sigrid K McAllister; Shailen N Banerjee; Martin E Schriefer; Jean B Patel
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

2.  In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.

Authors:  Jered M Wendte; Duraisamy Ponnusamy; Deanna Reiber; Jeffrey L Blair; Kenneth D Clinkenbeard
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

3.  Lovastatin protects against experimental plague in mice.

Authors:  Saravanan Ayyadurai; Hubert Lepidi; Claude Nappez; Didier Raoult; Michel Drancourt
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

4.  Rapid identification and antibiotic susceptibility testing of Yersinia pestis using bioluminescent reporter phage.

Authors:  David A Schofield; Ian J Molineux; Caroline Westwater
Journal:  J Microbiol Methods       Date:  2012-05-02       Impact factor: 2.363

5.  Metabolic network analysis-based identification of antimicrobial drug targets in category A bioterrorism agents.

Authors:  Yong-Yeol Ahn; Deok-Sun Lee; Henry Burd; William Blank; Vinayak Kapatral
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

6.  Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.

Authors:  Voahangy Andrianaivoarimanana; Eric Bertherat; Rojo Rajaonarison; Tiana Rakotondramaro; Christophe Rogier; Minoarisoa Rajerison
Journal:  BMC Pulm Med       Date:  2018-05-29       Impact factor: 3.317

Review 7.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12

8.  The Use of an Organo-Selenium Peptide to Develop New Antimicrobials That Target a Specific Bacteria.

Authors:  Phat Tran; Jonathan Kopel; Joe A Fralick; Ted W Reid
Journal:  Antibiotics (Basel)       Date:  2021-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.